
News|Podcasts|March 21, 2024
Phosgene at Valsynthese: An Atom-Economic Reagent That Demonstrates Exceptional Versatility
Author(s)Valsynthese
Dr. Luca Mantilli, R&D chemist at Valsynthese, the fine chemical unit of the Société Suisse des Explosifs Group (SSE), will guide you through the journey that Valsynthese as CDMO has done in phosgenation. The advantages and synthetic possibilities of phosgene, an extremely versatile reagent, will be highlighted with respect to other alternatives, same as the safety measures needed when working with such hazardous building blocks.
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5



